PT - JOURNAL ARTICLE AU - Kamil Malikov AU - Qing Huang AU - Shengli Shi AU - Nathan M. Stall AU - Ashleigh R. Tuite AU - Michael P. Hillmer TI - Temporal Associations between Community Incidence of COVID-19 and Nursing Home Outbreaks in Ontario, Canada AID - 10.1101/2020.11.17.20233312 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.17.20233312 4099 - http://medrxiv.org/content/early/2020/11/19/2020.11.17.20233312.short 4100 - http://medrxiv.org/content/early/2020/11/19/2020.11.17.20233312.full AB - The risk of nursing home COVID-19 outbreaks is strongly associated with the rate of infection in the communities surrounding homes, yet the temporal relationship between rising rates of community COVID-19 infection and the risk threshold for subsequent nursing home COVID-19 outbreaks is not well defined. This population-based cohort study included all COVID-19 cases in Canada’s most populous Province of Ontario between March 1-July 16, 2020. We evaluated the temporal relationship between trends in the number of active community COVID-19 cases and the number of nursing home outbreaks. We found that the average lag time between community cases and nursing home outbreaks was 23 days for Ontario overall, with substantial variability across geographic regions. We also determined thresholds of community incidence of COVID-19 associated with a 75% probability of observing a nursing home outbreak 5, 10 and 15 days into the future. For the province overall, when daily active COVID-19 community cases are 2.30 per 100,000 population, there is a 75% probability of a nursing home outbreak occurring five days later.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was not funded. Dr. Stall is supported by the University of Toronto Department of Medicine's Eliot Phillipson Clinician-Scientist Training Program and the Vanier Canada Graduate Scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Research Ethics Board of the University of Toronto.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy protocol and statistical code: The study protocol and underlying analytic code are available from the authors on request (e-mail, kamil.malikov@ontario.ca), with the understanding that the computer programs may rely on coding templates or macros that are unique to the Ontario Ministry of Health and therefore either are inaccessible or may require modification. Data set: The data used for this study are not publicly available.